REDWOOD CITY, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (Pulmonx or the “Company”), a global leader in minimally invasive treatments for severe lung disease, today reported financial results for the second quarter ended…
